Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains.

Nawatha M, Rogers JM, Bonn SM, Livneh I, Lemma B, Mali SM, Vamisetti GB, Sun H, Bercovich B, Huang Y, Ciechanover A, Fushman D, Suga H, Brik A.

Nat Chem. 2019 Jul;11(7):644-652. doi: 10.1038/s41557-019-0278-x. Epub 2019 Jun 10.

PMID:
31182821
2.

Modulation of the cell cycle regulating transcription factor E2F1 pathway by the proteasome following amino acid starvation.

Fabre B, Livneh I, Ziv T, Ciechanover A.

Biochem Biophys Res Commun. 2019 Jun 4;513(3):721-725. doi: 10.1016/j.bbrc.2019.04.066. Epub 2019 Apr 13.

PMID:
30992132
3.

Monitoring stress-induced autophagic engulfment and degradation of the 26S proteasome in mammalian cells.

Cohen-Kaplan V, Livneh I, Kwon YT, Ciechanover A.

Methods Enzymol. 2019;619:337-366. doi: 10.1016/bs.mie.2018.12.022. Epub 2019 Mar 7.

PMID:
30910028
4.

Diverse fate of ubiquitin chain moieties: The proximal is degraded with the target, and the distal protects the proximal from removal and recycles.

Sun H, Mali SM, Singh SK, Meledin R, Brik A, Kwon YT, Kravtsova-Ivantsiv Y, Bercovich B, Ciechanover A.

Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7805-7812. doi: 10.1073/pnas.1822148116. Epub 2019 Mar 13.

PMID:
30867293
5.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, Ciechanover A, Lee YJ, Kim BY, Kwon YT.

EMBO Rep. 2018 Sep;19(9). pii: e46380. doi: 10.15252/embr.201846380. No abstract available.

6.

N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis.

Yoo YD, Mun SR, Ji CH, Sung KW, Kang KY, Heo AJ, Lee SH, An JY, Hwang J, Xie XQ, Ciechanover A, Kim BY, Kwon YT.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2716-E2724. doi: 10.1073/pnas.1719110115. Epub 2018 Mar 5.

7.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

8.

The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation.

Shim SM, Choi HR, Sung KW, Lee YJ, Kim ST, Kim D, Mun SR, Hwang J, Cha-Molstad H, Ciechanover A, Kim BY, Kwon YT.

Sci Signal. 2018 Jan 2;11(511). pii: eaan0630. doi: 10.1126/scisignal.aan0630.

PMID:
29295953
9.

Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway.

Cha-Molstad H, Lee SH, Kim JG, Sung KW, Hwang J, Shim SM, Ganipisetti S, McGuire T, Mook-Jung I, Ciechanover A, Xie XQ, Kim BY, Kwon YT.

Autophagy. 2018;14(2):359-361. doi: 10.1080/15548627.2017.1415190. Epub 2018 Jan 29.

10.

Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.

Ciechanover A.

Best Pract Res Clin Haematol. 2017 Dec;30(4):341-355. doi: 10.1016/j.beha.2017.09.001. Epub 2017 Sep 22. Review.

PMID:
29156207
11.

HIF and HOIL-1L-mediated PKCζ degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury.

Magnani ND, Dada LA, Queisser MA, Brazee PL, Welch LC, Anekalla KR, Zhou G, Vagin O, Misharin AV, Budinger GRS, Iwai K, Ciechanover AJ, Sznajder JI.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10178-E10186. doi: 10.1073/pnas.1713563114. Epub 2017 Nov 6.

12.

The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy.

Kwon YT, Ciechanover A.

Trends Biochem Sci. 2017 Nov;42(11):873-886. doi: 10.1016/j.tibs.2017.09.002. Epub 2017 Sep 22. Review.

PMID:
28947091
13.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, Ciechanover A, Lee YJ, Kim BY, Kwon YT.

EMBO Rep. 2017 Sep;18(9):1671. doi: 10.15252/embr.201744761. No abstract available.

14.

p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis.

Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, Han B, Sung KW, Yoo YD, Hwang J, McGuire T, Shim SM, Song HD, Ganipisetti S, Wang N, Jang JM, Lee MJ, Kim SJ, Lee KH, Hong JT, Ciechanover A, Mook-Jung I, Kim KP, Xie XQ, Kwon YT, Kim BY.

Nat Commun. 2017 Jul 24;8(1):102. doi: 10.1038/s41467-017-00085-7.

15.

Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal.

Livneh I, Kravtsova-Ivantsiv Y, Braten O, Kwon YT, Ciechanover A.

Bioessays. 2017 Jun;39(6). doi: 10.1002/bies.201700027. Epub 2017 May 11. Review.

PMID:
28493408
16.

Protein Quality Control by Molecular Chaperones in Neurodegeneration.

Ciechanover A, Kwon YT.

Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Review.

17.

Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.

Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Lam S, Hsu S, Nelson N, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, Hoon DSB.

Clin Cancer Res. 2017 Aug 15;23(16):4831-4842. doi: 10.1158/1078-0432.CCR-17-0146. Epub 2017 Apr 7.

18.

The ubiquitin-proteasome system: A potential therapeutic target for heart failure.

Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A, Mohr FW, Aravot D, Taylor DA.

J Heart Lung Transplant. 2017 Jul;36(7):708-714. doi: 10.1016/j.healun.2017.02.012. Epub 2017 Feb 20. Review.

PMID:
28341100
19.

Immune defects caused by mutations in the ubiquitin system.

Etzioni A, Ciechanover A, Pikarsky E.

J Allergy Clin Immunol. 2017 Mar;139(3):743-753. doi: 10.1016/j.jaci.2016.11.031. Review.

PMID:
28270366
20.

Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation.

Cohen-Kaplan V, Ciechanover A, Livneh I.

Autophagy. 2017 Apr 3;13(4):759-760. doi: 10.1080/15548627.2016.1278327. Epub 2017 Jan 25.

21.

Identification of UBact, a ubiquitin-like protein, along with other homologous components of a conjugation system and the proteasome in different gram-negative bacteria.

Lehmann G, Udasin RG, Livneh I, Ciechanover A.

Biochem Biophys Res Commun. 2017 Feb 12;483(3):946-950. doi: 10.1016/j.bbrc.2017.01.037. Epub 2017 Jan 10.

PMID:
28087277
22.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Yoo YD, Lee DH, Cha-Molstad H, Kim H, Mun SR, Ji C, Park SH, Sung KS, Choi SA, Hwang J, Park DM, Kim SK, Park KJ, Kang SH, Oh SC, Ciechanover A, Lee YJ, Kim BY, Kwon YT.

EMBO Rep. 2017 Jan;18(1):150-168. doi: 10.15252/embr.201642360. Epub 2016 Dec 19. Erratum in: EMBO Rep. 2017 Sep;18(9):1671. EMBO Rep. 2018 Sep;19(9):.

23.

p62 at the crossroad of the ubiquitin-proteasome system and autophagy.

Cohen-Kaplan V, Ciechanover A, Livneh I.

Oncotarget. 2016 Dec 20;7(51):83833-83834. doi: 10.18632/oncotarget.13805. No abstract available.

24.

The testis-specific USP26 is a deubiquitinating enzyme of the ubiquitin ligase Mdm2.

Lahav-Baratz S, Kravtsova-Ivantsiv Y, Golan S, Ciechanover A.

Biochem Biophys Res Commun. 2017 Jan 1;482(1):106-111. doi: 10.1016/j.bbrc.2016.10.135. Epub 2016 Oct 31.

PMID:
27810359
25.

p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome.

Cohen-Kaplan V, Livneh I, Avni N, Fabre B, Ziv T, Kwon YT, Ciechanover A.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7490-E7499. Epub 2016 Oct 17.

26.

A path toward understanding neurodegeneration.

Kosik KS, Sejnowski TJ, Raichle ME, Ciechanover A, Baltimore D.

Science. 2016 Aug 26;353(6302):872-3. doi: 10.1126/science.aai7622. No abstract available.

27.

The ubiquitin-proteasome system and autophagy: Coordinated and independent activities.

Cohen-Kaplan V, Livneh I, Avni N, Cohen-Rosenzweig C, Ciechanover A.

Int J Biochem Cell Biol. 2016 Oct;79:403-418. doi: 10.1016/j.biocel.2016.07.019. Epub 2016 Jul 20. Review.

PMID:
27448843
28.

The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death.

Livneh I, Cohen-Kaplan V, Cohen-Rosenzweig C, Avni N, Ciechanover A.

Cell Res. 2016 Aug;26(8):869-85. doi: 10.1038/cr.2016.86. Epub 2016 Jul 22. Review.

29.

Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination.

Braten O, Livneh I, Ziv T, Admon A, Kehat I, Caspi LH, Gonen H, Bercovich B, Godzik A, Jahandideh S, Jaroszewski L, Sommer T, Kwon YT, Guharoy M, Tompa P, Ciechanover A.

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):E4639-47. doi: 10.1073/pnas.1608644113. Epub 2016 Jul 6.

30.

The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.

Kravtsova-Ivantsiv Y, Ciechanover A.

Mol Cell Oncol. 2015 May 26;2(4):e1054552. doi: 10.1080/23723556.2015.1054552. eCollection 2015 Oct-Dec.

31.

Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer.

Eisenberg-Lerner A, Ciechanover A, Merbl Y.

Exp Biol Med (Maywood). 2016 Aug;241(14):1475-82. doi: 10.1177/1535370216651732. Epub 2016 May 26. Review.

32.

Ubiquitination of specific mitochondrial matrix proteins.

Lehmann G, Ziv T, Braten O, Admon A, Udasin RG, Ciechanover A.

Biochem Biophys Res Commun. 2016 Jun 17;475(1):13-8. doi: 10.1016/j.bbrc.2016.04.150. Epub 2016 May 5.

PMID:
27157140
33.

On the linkage between the ubiquitin-proteasome system and the mitochondria.

Lehmann G, Udasin RG, Ciechanover A.

Biochem Biophys Res Commun. 2016 Apr 22;473(1):80-86. doi: 10.1016/j.bbrc.2016.03.055. Epub 2016 Mar 18.

PMID:
26996128
34.

Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations.

Mollereau B, Rzechorzek NM, Roussel BD, Sedru M, Van den Brink DM, Bailly-Maitre B, Palladino F, Medinas DB, Domingos PM, Hunot S, Chandran S, Birman S, Baron T, Vivien D, Duarte CB, Ryoo HD, Steller H, Urano F, Chevet E, Kroemer G, Ciechanover A, Calabrese EJ, Kaufman RJ, Hetz C.

Brain Res. 2016 Oct 1;1648(Pt B):603-616. doi: 10.1016/j.brainres.2016.02.033. Epub 2016 Mar 2. Review.

35.

Modulation of SQSTM1/p62 activity by N-terminal arginylation of the endoplasmic reticulum chaperone HSPA5/GRP78/BiP.

Cha-Molstad H, Yu JE, Lee SH, Kim JG, Sung KS, Hwang J, Yoo YD, Lee YJ, Kim ST, Lee DH, Ciechanover A, Kim BY, Kwon YT.

Autophagy. 2016;12(2):426-8. doi: 10.1080/15548627.2015.1126047.

36.

Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding.

Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, Jang JM, Han DH, Molstad M, Kim JG, Lee YJ, Zakrzewska A, Kim SH, Kim ST, Kim SY, Lee HG, Soung NK, Ahn JS, Ciechanover A, Kim BY, Kwon YT.

Nat Cell Biol. 2015 Jul;17(7):917-29. doi: 10.1038/ncb3177. Epub 2015 Jun 15.

37.

The unravelling of the ubiquitin system.

Ciechanover A.

Nat Rev Mol Cell Biol. 2015 May;16(5):322-4. doi: 10.1038/nrm3982. Review.

PMID:
25907614
38.

KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.

Kravtsova-Ivantsiv Y, Shomer I, Cohen-Kaplan V, Snijder B, Superti-Furga G, Gonen H, Sommer T, Ziv T, Admon A, Naroditsky I, Jbara M, Brik A, Pikarsky E, Kwon YT, Doweck I, Ciechanover A.

Cell. 2015 Apr 9;161(2):333-47. doi: 10.1016/j.cell.2015.03.001.

39.

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.

Ciechanover A, Kwon YT.

Exp Mol Med. 2015 Mar 13;47:e147. doi: 10.1038/emm.2014.117. Review.

40.

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Muñoz-Pinedo C, Nuñez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G.

Cell Death Differ. 2015 Jan;22(1):58-73. doi: 10.1038/cdd.2014.137. Epub 2014 Sep 19. Review.

41.

Israel-Gaza conflict.

Ahmed Q, Avidan AY, Ciechanover A, Shechtman D, Zajfman D, Reichman U, Kornberg R, Hershko A, Lavie P.

Lancet. 2014 Aug 30;384(9945):e34-7. doi: 10.1016/S0140-6736(14)61314-3. Epub 2014 Aug 18. No abstract available.

PMID:
25145777
42.

HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.

Queisser MA, Dada LA, Deiss-Yehiely N, Angulo M, Zhou G, Kouri FM, Knab LM, Liu J, Stegh AH, DeCamp MM, Budinger GR, Chandel NS, Ciechanover A, Iwai K, Sznajder JI.

Am J Respir Crit Care Med. 2014 Sep 15;190(6):688-98. doi: 10.1164/rccm.201403-0463OC.

43.

High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.

Rossi M, Rotblat B, Ansell K, Amelio I, Caraglia M, Misso G, Bernassola F, Cavasotto CN, Knight RA, Ciechanover A, Melino G.

Cell Death Dis. 2014 May 1;5:e1203. doi: 10.1038/cddis.2014.113.

44.

Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation.

Belogurov A Jr, Kudriaeva A, Kuzina E, Smirnov I, Bobik T, Ponomarenko N, Kravtsova-Ivantsiv Y, Ciechanover A, Gabibov A.

J Biol Chem. 2014 Jun 20;289(25):17758-66. doi: 10.1074/jbc.M113.544247. Epub 2014 Apr 16.

45.

Nonenzymatic polyubiquitination of expressed proteins.

Hemantha HP, Bavikar SN, Herman-Bachinsky Y, Haj-Yahya N, Bondalapati S, Ciechanover A, Brik A.

J Am Chem Soc. 2014 Feb 12;136(6):2665-73. doi: 10.1021/ja412594d. Epub 2014 Jan 31.

46.

A conversation with Aaron Ciechanover. Interview by Ushma S. Neill.

Ciechanover A.

J Clin Invest. 2013 Oct;123(10):4093-4. doi: 10.1172/JCI71859. Epub 2013 Oct 1. No abstract available.

47.

Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology.

Haj-Yahya M, Fauvet B, Herman-Bachinsky Y, Hejjaoui M, Bavikar SN, Karthikeyan SV, Ciechanover A, Lashuel HA, Brik A.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17726-31. doi: 10.1073/pnas.1315654110. Epub 2013 Sep 16.

48.

Modifying the vicinity of the isopeptide bond to reveal differential behavior of ubiquitin chains with interacting proteins: organic chemistry applied to synthetic proteins.

Haj-Yahya N, Haj-Yahya M, Castañeda CA, Spasser L, Hemantha HP, Jbara M, Penner M, Ciechanover A, Fushman D, Brik A.

Angew Chem Int Ed Engl. 2013 Oct 11;52(42):11149-53. doi: 10.1002/anie.201306118. Epub 2013 Sep 4.

49.

The complexity of recognition of ubiquitinated substrates by the 26S proteasome.

Ciechanover A, Stanhill A.

Biochim Biophys Acta. 2014 Jan;1843(1):86-96. doi: 10.1016/j.bbamcr.2013.07.007. Epub 2013 Jul 18. Review.

50.

Ubiquitin binding by a CUE domain regulates ubiquitin chain formation by ERAD E3 ligases.

Bagola K, von Delbrück M, Dittmar G, Scheffner M, Ziv I, Glickman MH, Ciechanover A, Sommer T.

Mol Cell. 2013 May 23;50(4):528-39. doi: 10.1016/j.molcel.2013.04.005. Epub 2013 May 9.

Supplemental Content

Loading ...
Support Center